<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T02:23:29Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/29115" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/29115</identifier><datestamp>2026-09-24T07:08:27Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Rullo, Anthony</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author">Yang, Zi Ling (Sissi)</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Chemistry and Chemical Biology</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2023-10-24T19:59:05Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2023-10-24T19:59:05Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2023-11</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/29115</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/24693</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">Antibody-recruiting molecules (ARMs) are therapeutic tools that simultaneously &#xd;
bind a hapten-specific serum antibody and a cancer cell surface protein, resulting in the &#xd;
activation and recruitment of an immune cell to the cancer surface. However, ARM &#xd;
efficacy is limited by the ability of ARMs to form a quaternary complex with the immune &#xd;
cell receptor, antibody, and cancer cell surface. The Rullo lab has previously developed &#xd;
and characterized a covalent ARM (cARM) that irreversibly links the ARM to the &#xd;
antibody and simplifies the quaternary binding equilibria. cARMs have shown a marked &#xd;
increase in both target immune recognition and therapeutic efficacy. However, cARM &#xd;
efficacy is still limited by the affinity of the antibody for the immune receptor. We aim to &#xd;
investigate how direct covalent engagement of the immune receptor and elimination the &#xd;
antibody-immune receptor binding equilibria impacts immune activation and therapeutic &#xd;
efficacy. &#xd;
This thesis focuses on the chemical programming of macrophages through direct &#xd;
covalent immune receptor engagement. We have developed and characterized covalent &#xd;
immune programmers (CIPs), which are molecules that contain a macrophage targeting &#xd;
domain and a tumour targeting domain. The macrophage targeting domain binds the&#xd;
activating receptor CD64 on the macrophage surface and contains a chemical warhead &#xd;
that covalently labels the receptor once bound. The tumour targeting domain can &#xd;
promote macrophage tumour engagement resulting in tumoricidal function. Flow &#xd;
cytometry experiments have shown that CIPS are able to bind Fc receptors specifically &#xd;
and effectively on the surface of macrophages. Further, CIPs were able to induce &#xd;
macrophage activation and induce target specific phagocytosis. These experiments &#xd;
have also shown that direct engagement of the receptor by the CIP is more effective &#xd;
than antibody-mediated engagement, suggesting that overall immune complex stability &#xd;
affects immune cell activation. Taken together, these concepts can be used to guide &#xd;
future immunotherapeutic design.</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degreetype" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Master of Science (MSc)</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en_US">en</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Chemical Immunology</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Immunotherapy</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Macrophage Programming</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Peptide Drugs</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Covalent Drugs</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Proximity Induced Labeling</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Cancer</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">Chemical Programming of Macrophages via Direct Activating Receptor Labeling for Targeted Tumour Immunotherapy</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>